In accordance with the instruction for the Nomination Committee, which was adopted at Oasmia Pharmaceutical AB's ('Oasmia') Annual General Meeting on 27 May 2021, it is hereby announced that the Nomination Committee for the 2022 Annual General Meeting has been appointed, based on the ownership structure as per 30 September 2021. The Nomination Committee for the 2022 Annual General Meeting comprises the following members: Per Arwidsson, appointed by Arwidsro Investment AB, Hakan Lagerberg, appointed by Mastan AB, and Anders Harfstrand, Chairman of the Board of Oasmia. Per Arwidsson has been appointed Chairman of the Nomination Committee.